decorative image
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
decorative image
Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.
seed logo
small business image

[Omnibus Solicitations] [Specific Opportunities]

SBIR and STTR grant funding opportunities offer small business entrepreneurs a chance to obtain non-dilutive funding for early-stage research and development. Applications are accepted three times a year. 

NIH advertises the availability of grant support through notices of funding opportunities (NOFOs), previously referred to as funding opportunity announcements (FOAs).

Looking for NIH SBIR contracts? View open SBIR contract solicitations.

 

Helpful Tips

Omnibus Solicitations (Parent Announcements)

Researcher-initiated ideas are proposed via the SBIR and STTR Omnibus grant solicitations. These funding opportunities do not specify a topic, though they link to identified topics of interest for each participating awarding component. Most small business applications to NIH are submitted to the Omnibus solicitations.

Read the Program Descriptions and Research Topics to understand the awarding components, their topics of interest, and staff contacts. For topics that require additional funding to reach the marketplace, please refer to our list of SBA approved waiver eligible topics.

Standard Application Due Dates: September 5, January 5, and April 5. Due dates that fall on weekends or Federal holidays move to the next business day.

 

PHS 2023-2 Omnibus Solicitations

These are the PHS 2023-2 Omnibus Solicitations of the NIH, CDC, and FDA for Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) grant applications.

Title Notice/FOA Number Organization Release Date Due Date(s) Expiration Date Clinical Trials
PHS 2023-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required) PA-23-231 NIH 07/12/2023 Multiple dates, see announcement....(see announcement for full details) 04/06/2024 Required
PHS 2023-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed) PA-23-232 NIH 07/12/2023 Multiple dates, see announcement....(see announcement for full details) 04/06/2024 Not Allowed
PHS 2023-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required) PA-23-233 NIH 07/12/2023 Multiple dates, see announcement....(see announcement for full details) 04/06/2024 Required
PHS 2023-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) PA-23-230 NIH 07/12/2023 Multiple dates, see announcement....(see announcement for full details) 04/06/2024 Not Allowed

Specific Funding Opportunities

Some SBIR/STTR grant solicitations are focused on specific research areas. Some specific NOFOs, identified as RFAs (Requests for Applications) or PASs (Program Announcements with Set-aside funds), have funding set-aside in the Institute/Center's budget for that targeted program.

Title Notice/FOA Number Organization Release Date Due Date(s) Expiration Date Clinical Trials
Addressing Health Inequities in Clinical Diagnostics (R41/R42 Clinical Trials Not Allowed) PAR-24-157 NCATSNEINHGRINIAMSNIDCDSGMRO 02/28/2024 01/06/2027 Not Allowed
Addressing Health Inequities in Clinical Diagnostics (R43/R44 Clinical Trials Not Allowed) PAR-24-158 NCATSNEINHGRINIAMSNIDCDSGMRO 02/28/2024 01/06/2027 Not Allowed
Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional) PAS-22-197 NIANINDS 06/21/2022 09/06/2025 Optional
Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional) PAS-22-196 NIANINDS 06/21/2022 09/06/2025 Optional
Analytical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U44 Clinical Trial Optional) PAR-24-098 NINDS 01/22/2024 Multiple dates, see announcement....(see announcement for full details) 06/26/2026 Optional
Basket Clinical Trials of Drugs Targeting Shared Molecular Etiologies in Multiple Rare Diseases (U44 Clinical Trial Required) RFA-TR-24-001 NCATS 12/01/2023 03/16/2024 Required
Blueprint Medtech: Small Business Translator (U44 - Clinical Trial Optional) PAR-21-282 NIDANIMHNEINIDCRNIAOBSSRNCCIHNIBIBNICHDNIAAANINDS 08/20/2021 October 20, 2021; February 18, 2022; June 20, 2022...(see announcement for full details) 06/21/2024 Optional
Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional) PAR-21-233 NINDSNIAAANIANCCIHNICHDNIBIBNIMHOBSSRNIDCRNIDANEI 04/23/2021 August 10, 2021, February 9, 2022, August 9, 2022,...(see announcement for full details) 04/06/2024 Optional
Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional) PAR-24-063 NINDSNCCIHNEINIANIAAANICHDNIDANIDCRNIMHOBSSR 11/01/2023 08/19/2026 Optional
Clinical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U44 Clinical Trial Optional) PAR-24-096 NINDS 01/22/2024 Multiple dates, see announcement....(see announcement for full details) 06/23/2026 Optional
Developing Regulated Therapeutic and Diagnostic Solutions for Patients Affected by Opioid and/or Stimulants use Disorders (OUD/StUD) (R41/R42 Clinical Trial Optional) RFA-DA-24-038 NIDA 04/18/2023 02/15/2025 Optional
Developing Regulated Therapeutic and Diagnostic Solutions for Patients Affected by Opioid and/or Stimulants use Disorders (OUD/StUD) (R43/R44 - Clinical Trial Optional) RFA-DA-23-021 NIDA 03/28/2022 Multiple dates, see announcement....(see announcement for full details) 02/15/2025 Optional
Harnessing Artificial Intelligence and Polypharmacology to Discover Pharmacotherapeutics for Substance Use Disorders (R41/R42 Clinical Trials Not Allowed) RFA-DA-25-053 NIDA 01/29/2024 07/26/2024 Not Allowed
Harnessing Artificial Intelligence and Polypharmacology to Discover Pharmacotherapeutics for Substance Use Disorders (R43/R44 Clinical Trials Not Allowed) RFA-DA-25-054 NIDA 01/29/2024 July 25, 2024...(see announcement for full details) 07/26/2024 Not Allowed
HEAL Commercialization Readiness Pilot (CRP) Program: Embedded Entrepreneurs for Small Businesses in Pain Management (SB1 Clinical Trial Not Allowed) PAR-23-069 NINDSNCATSNCCIHNEINIAMS 01/03/2023 09/06/2025 Not Allowed
HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Not Allowed) RFA-NS-23-007 NINDSNCATSNCCIHNCINHLBINIANIAAANIAMSNICHDNIDCRNIGMSNIMHORIP 09/15/2022 Multiple dates, see announcement....(see announcement for full details) 04/05/2025 Not Allowed
HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 Clinical Trial Not Allowed) RFA-NS-23-006 NINDSNCATSNCCIHNHLBINIANIAAANIAMSNICHDNIDCRNIGMSNIMHORIP 09/15/2022 Multiple dates, see announcement....(see announcement for full details) 04/05/2025 Not Allowed
High-Throughput Screening (HTS) Platform for Discovery of Medications to Treat Alcohol Use Disorder (R41/R42 Clinical Trials Not Allowed) RFA-AA-24-002 NIAAA 12/21/2023 04/10/2024 Not Allowed
High-Throughput Screening (HTS) Platform for Discovery of Medications to Treat Alcohol Use Disorder (R43/R44 Clinical Trials Not Allowed) RFA-AA-24-001 NIAAA 12/21/2023 04/10/2024 Not Allowed
Industrialization and Translation of Extracellular Vesicles for use in Regenerative Medicine (U43/U44 Clinical Trials Not Allowed) PAR-23-267 NCATS 04/18/2023 Multiple dates, see announcement....(see announcement for full details) 06/07/2025 Not Allowed
Industrialization and Translation of Extracellular Vesicles for use in Regenerative Medicine (UT1/UT2) Clinical Trial Not Allowed PAR-23-268 NCATS 04/18/2023 06/07/2025 Not Allowed
Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities (R43/R44 - Clinical Trial Optional) RFA-MD-24-006 NIMHDNCATSNHLBINIANIBIBNIDCRNIDDKNINR 03/08/2024 Multiple dates, see announcement....(see announcement for full details) 12/10/2026 Optional
Interactive Digital Media (IDM) Biomedical Science Resources for Pre-College Students and Teachers (SBIR) (R43/R44 Clinical Trial Not Allowed) PAR-23-213 NIGMS 06/15/2023 09/06/2025 Not Allowed
Investigational New Drug (IND)-enabling and Early-Stage Development of Medications to Treat Alcohol Use disorder and Alcohol-Associated Organ Damage (U43/U44 Clinical Trial Optional) PAR-22-102 NIAAA 01/21/2022 Multiple dates, see announcement....(see announcement for full details) 12/05/2024 Optional
Investigational New Drug (IND)-enabling and Early-Stage Development of Medications to Treat Alcohol Use disorder and Alcohol-Associated Organ Damage (UT1/UT2 Clinical Trial Optional) PAR-22-103 NIAAA 01/21/2022 Multiple dates, see announcement....(see announcement for full details) 12/05/2024 Optional
Late-Stage Translation of Biomedical and Behavioral Research Results in Arthritis and Musculoskeletal and Skin Diseases from Academic/Non-profit Lab to Marketplace (SBIR [R43/R44] Clinical Trial Not Allowed) PAR-23-032 NIAMS 10/26/2022 09/06/2025 Not Allowed
Miniaturization and Automation of Tissue Chip Systems (MATChS) (U43/U44 Clinical Trial Not Allowed) RFA-TR-23-017 NCATS 11/21/2023 Multiple dates, see announcement....(see announcement for full details) 02/24/2026 Not Allowed
Miniaturization and Automation of Tissue Chip Systems (MATChS) (UT1/UT2 - Clinical Trial Not Allowed) RFA-TR-23-018 NCATS 11/21/2023 Multiple dates, see announcement....(see announcement for full details) 02/24/2026 Not Allowed
NEI Small Business Innovation Research (SBIR) Cooperative Agreement for Early-Stage Clinical Trials with Greater than Minimal Risk (U44-Clinical Trial Required) PAR-24-066 NEI 12/01/2023 Multiple dates, see announcement....(see announcement for full details) 01/08/2027 Required
NeuroNEXT Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional) PAR-21-224 NINDS 05/05/2021 Standard dates apply *** Note new SBIR/STTR Standa...(see announcement for full details) 09/06/2024 Optional
NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (U44 Clinical Trial Required) PAR-24-099 NIAID 01/29/2024 Multiple dates, see announcement....(see announcement for full details) 01/14/2027 Required
NINDS Exploratory Clinical Trials for Small Business (R41/R42 Clinical Trial Required) PAR-24-044 NINDS 11/27/2023 Multiple dates, see announcement....(see announcement for full details) 09/06/2026 Required
NINDS Exploratory Clinical Trials for Small Business (R43/R44 Clinical Trial Required) PAR-23-311 NINDS 11/27/2023 Multiple dates, see announcement....(see announcement for full details) 09/06/2026 Required
NINDS Renewal Awards of SBIR Phase II Grants (Phase IIB) for Clinical Trials and Clinical Research (R44 Clinical Trial Optional) PAR-21-265 NINDS 07/15/2021 Standard dates apply The first standard due date f...(see announcement for full details) 04/06/2024 Optional
NINDS Renewal Awards of SBIR Phase II Grants (Phase IIB) for Pre-Clinical Research (R44 Clinical Trial Not Allowed) PAR-21-114 NINDS 01/25/2021 Standard dates apply The first standard due date f...(see announcement for full details) 04/06/2024 Not Allowed
Notice of Change for PAR-24-066 NEI Small Business Innovation Research (SBIR) Cooperative Agreement for Early-Stage Clinical Trials with Greater than Minimal Risk (U44-Clinical Trial Required). NOT-EY-24-002 NEI 02/28/2024 01/08/2027 Optional
Notice of Special Interest (NOSI): Accelerating Progress in Celiac Disease Research NOT-AI-22-004 NIAIDNIAMSNCCIHNCI 11/23/2021 01/08/2025 Optional
Notice of Special Interest (NOSI): Advancing NEI AGI Research on newly Identified Factors Into Models of Visual System Regeneration NOT-EY-22-002 NEI 01/10/2022 02/10/2025 Optional
Notice of Special Interest (NOSI): HIV Drug Resistance Assays and Actionable Data Dissemination Strategies NOT-AI-21-056 NIAIDNIDA 06/17/2021 05/08/2024 Not Allowed
Notice of Special Interest (NOSI): Methods Development for Genomic Studies of Genetic Variation, Function, and Disease NOT-HG-22-007 NHGRI 12/09/2021 11/05/2024 Not Allowed
Notice of Special Interest (NOSI): The Road to Prevention of Stillbirth NOT-HD-23-021 NICHD 10/03/2023 11/17/2026 Optional
Notice of Special Interest (NOSI): Addressing Health Disparities and Advancing Health Equity in NIDDK Diseases NOT-DK-24-007 NIDDK 12/20/2023 01/08/2027 Optional
Notice of Special Interest (NOSI): Advancing Biomedical Research in Pulmonary Non-Tuberculous Mycobacterial (NTM) Infections NOT-AI-23-050 NIAID 06/27/2023 07/17/2026 Optional
Notice of Special Interest (NOSI): Advancing Development of Rapid Point-of-Care Hepatitis C Virus Diagnostics NOT-AI-23-001 NIAIDNCINIBIB 11/23/2022 01/08/2026 Not Allowed
Notice of Special Interest (NOSI): Advancing Genomic Medicine Research through Small Businesses NOT-HG-24-002 NHGRI 10/11/2023 09/07/2026 Not Allowed
Notice of Special Interest (NOSI): Advancing Genomic Medicine Research through Small Businesses NOT-HG-24-016 NHGRI 02/14/2024 09/07/2026 Optional
Notice of Special Interest (NOSI): Advancing Genomic Technology Development for Research and Clinical Application NOT-HG-24-012 NHGRI 12/20/2023 01/10/2027 Not Allowed
Notice of Special Interest (NOSI): Advancing Imaging, Device Production, and Clinical Capabilities in Digital Dentistry (R41/R42, R43/R44 Clinical Trial Not Allowed) NOT-DE-21-012 NIDCR 09/01/2021 09/05/2025 Not Allowed
Notice of Special Interest (NOSI): Advancing Innovative Non-invasive Physiologic Monitoring To Improve Fetal Assessment NOT-HD-21-053 NICHD 12/28/2021 05/08/2024 Optional
Notice of Special Interest (NOSI): Advancing Research for Tickborne Diseases (TBDs) NOT-AI-23-013 NIAIDNIAMSNIMHNINDS 11/25/2022 01/08/2026 Optional
Notice of Special Interest (NOSI): Advancing Research Needed to Develop a Coccidioidomycosis (Valley fever) Vaccine NOT-AI-23-007 NIAID 11/25/2022 01/08/2026 Optional
Notice of Special Interest (NOSI): Advancing Research Needed to Develop a Coccidioidomycosis (Valley fever) Vaccine NOT-AI-23-031 NIAID 02/23/2023 01/15/2026 Optional
Notice of Special Interest (NOSI): Applications of Data Science in Translational Dental, Oral, and Craniofacial Research NOT-DE-24-003 NIDCR 10/23/2023 05/08/2026 Optional
Notice of Special Interest (NOSI): BRAIN Initiative: Translation of Groundbreaking Technologies from Early-stage Development through Early Clinical Study via Blueprint MedTech NOT-NS-22-052 NINDSNIAAANIBIBNCCIHNEINIANICHDOBSSRNIDCDNIDANIMH 01/05/2022 06/21/2024 Optional
Notice of Special Interest (NOSI): Development of Functional Assay Sites to Evaluate Candidate -Omics Variants Associated with Heart, Lung, Blood, or Sleep Disease (R01, R41, R42, R43, R44) NOT-HL-23-066 NHLBI 01/31/2023 09/08/2026 Optional
Notice of Special Interest (NOSI): Development of Innovative Informatics and Data Science Technologies, Tools, and Methods for Vision Research NOT-EY-23-005 NEI 04/03/2023 02/16/2026 Not Allowed
Notice of Special Interest (NOSI): Developmentally Tailored HIV Prevention and Care Research for Adolescents and Young Adults NOT-MH-23-250 NIMH 05/19/2023 09/08/2026 Optional
Notice of Special Interest (NOSI): Epidemiology and Prevention of Alcohol Misuse in Understudied Young Adult Populations; Military, Workforce, and Community College NOT-AA-22-001 NIAAA 12/09/2021 09/09/2025 Optional
Notice of Special Interest (NOSI): Genomics Education Interactive Digital Media Resources (SBIR/STTR) NOT-HG-21-038 NHGRI 08/26/2021 12/31/2024 Not Allowed
Notice of Special Interest (NOSI): HEAL Initiative: Clinical Translation of Diagnostic and Therapeutic Devices via Blueprint MedTech NOT-NS-23-002 NINDSNCCIHNCINEINIANIAAANIAMSNICHDNIDANIDCRNIMH 08/03/2022 06/21/2024 Optional
Notice of Special Interest (NOSI): Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health NOT-OD-21-100 OBSSRNIMHDNIDANIMHORWHNIDCDSGMROODPNIANHLBINCININRNCCIHNEINICHD 04/08/2021 06/08/2024 Optional
Notice of Special Interest (NOSI): Innovative Technologies for Research on Climate Change and Human Health NOT-ES-24-002 NIEHSNCATSNEINHLBINIANIAIDNIAMSNLM 02/15/2024 04/06/2025 Optional
Notice of Special Interest (NOSI): Innovative Technologies to develop novel tools to prevent and treat HIV in underserved populations NOT-MH-23-200 NIMHSGMRO 07/18/2023 01/06/2027 Optional
Notice of Special Interest (NOSI): National Cancer Institute SBIR/STTR Program Announcement Regarding Cancer Prevention, Diagnosis, and Treatment Technologies for Low-Resource Settings NOT-CA-21-062 NCI 07/23/2021 09/07/2024 Optional
Notice of Special Interest (NOSI): Next-Generation Approaches to Renal Replacement Therapy Including Vascular Access NOT-DK-23-015 NIDDKNCATSNIBIB 08/14/2023 04/07/2025 Not Allowed
Notice of Special Interest (NOSI): NIDCD is Interested in Supporting Research on the Impact of Post-Acute Sequelae of SARS-CoV-2 Infection on Mission Specific Sensory and Communication Disorders NOT-DC-24-001 NIDCD 12/14/2023 01/30/2027 Optional
Notice of Special Interest (NOSI): Optimization of Data Storage and Utilization for the Sequence Read Archive (SRA) NOT-GM-23-015 NIGMSNLMODSS 12/14/2022 12/19/2025 Optional
Notice of Special Interest (NOSI): Priority Research Opportunities in Crisis Response Services NOT-MH-22-110 NIMHNIDAORWH 02/08/2022 05/08/2025 Optional
Notice of Special Interest (NOSI): Promoting Language and Communication in Minimally Verbal/Non-Speaking Individuals with Autism NOT-DC-23-009 NIDCD 04/03/2023 06/06/2026 Optional
Notice of Special Interest (NOSI): Promoting Research and Development of Vaccines Against Enteric Viruses NOT-AI-23-048 NIAID 06/15/2023 07/17/2026 Optional
Notice of Special Interest (NOSI): Quantum Sensing in Biomedical Applications (SBIR/STRR) NOT-EY-23-009 NEINCATSNCI 09/06/2023 09/06/2024 Optional
Notice of Special Interest (NOSI): Research Addressing Eye and Vision Health Equity/Health Disparities NOT-EY-22-004 NEINIMHD 02/14/2022 01/25/2025 Optional
Notice of Special Interest (NOSI): RNA Delivery Technologies to Allow Specific Tissue Target Homing (RNA-DASH) NOT-AI-24-007 NIAIDNCATSNCI 02/02/2024 01/06/2027 Not Allowed
Notice of Special Interest (NOSI): SBIR/STTR High-Priority Areas for Digital Mental Health Innovations NOT-MH-24-120 NIMH 11/29/2023 01/06/2027 Optional
Notice of Special Interest (NOSI): SBIR/STTR Program Priorities to Bridge Gaps in Advancing the NIMH Mission NOT-MH-24-110 NIMH 11/29/2023 01/06/2027 Optional
Notice of Special Interest (NOSI): Small Business Digital Technologies for Early Detection, Characterization and Monitoring of Senescence-Related Changes NOT-AG-23-004 NIA 02/07/2023 01/06/2026 Optional
Notice of Special Interest (NOSI): Small Business Initiatives for Innovative tools and Technologies for Improving Outcomes for Maternal Health NOT-EB-23-005 NIBIBNCATSNHLBINIAMSNIMHNIMHDNINDSORWH 07/26/2023 09/06/2026 Optional
Notice of Special Interest (NOSI): Synthetic Biology for Biomedical Applications. NOT-EB-23-002 NIBIBNCCIHNCINHLBINIANIAIDNICHDNIGMS 04/14/2023 05/17/2026 Optional
Notice of Special Interest (NOSI): Technological Innovations for Advancing Clinical SPECT Imaging NOT-EB-22-006 NIBIB 03/21/2022 05/08/2024 Optional
Notice of Special Interest (NOSI): Towards Developing a Cure for HBV in HIV/HBV Co-Infection NOT-AI-22-043 NIAID 04/29/2022 05/08/2025 Not Allowed
Notice of Special Interest (NOSI): Translation of BRAIN Initiative Technologies to the Marketplace NOT-MH-24-115 NIMHNCCIHNEINIANIAAANIBIBNICHDNIDANIDCDNINDS 01/08/2024 04/06/2027 Not Allowed
Notice of Special Interest (NOSI): Using Targeted Degradation of Protein and non-Protein Targets for the Development of Novel Anti-Infectives NOT-AI-23-076 NIAID 10/31/2023 07/17/2026 Not Allowed
Notice of Special Interest (NOSI): Using Targeted Degradation of Protein and non-Protein Targets for the Development of Novel Anti-Infectives NOT-AI-23-049 NIAID 06/23/2023 07/17/2026 Not Allowed
Notice of Special Interest (NOSI): Utilization of Cohorts and Prospective Study Designs for Liquid Biopsy Assay Validation for Early Detection of Cancers NOT-CA-23-004 NCI 10/17/2022 07/02/2025 Optional
Notice of Special Interest (NOSI): Validation of Digital Health and Artificial Intelligence/Machine Learning Tools for Improved Assessment in Biomedical and Behavioral Research NOT-CA-24-031 NCINHLBINIANIDANIMHNINROBSSRODSS 02/15/2024 07/06/2025 Optional
Notice of Special Interest: Biomarker Discover and Validation in Functional Neurological Disorders NOT-NS-22-010 NINDS 10/01/2021 01/08/2025 Optional
Notice of Special Interest: Development and Implementation of Clinical Informatics Tools to Enhance Patients Use of Genomic Information NOT-HG-22-011 NHGRI 01/06/2022 12/31/2025 Optional
Notice of Special Interest: Development of Radiotracers for Diagnosis and Clinical Studies in Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) NOT-AG-22-032 NIA 09/28/2022 09/05/2025 Optional
Notice of Special Interest: Encouraging Small Businesses to Partner with Resource-Limited Institutions (RLIs) on Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Program Applications NOT-OD-23-179 OD 10/03/2023 04/06/2024 Optional
Notice of Special Interest: NIDCD Health Disparities and Inequities Research NOT-DC-21-003 NIDCDSGMRO 06/11/2021 05/08/2024 Optional
Notice of Special Interest: Research on Pain, Pain Management, and Opioids in Aging NOT-AG-22-004 NIA 12/22/2021 01/08/2025 Optional
Notice of Special Interest: SBIR Technology Transfer (R43/R44 Clinical Trial Not Allowed) NOT-NS-22-017 NINDSNIDCRNEINCINIA 11/12/2021 01/08/2025 Not Allowed
Novel Tools and Devices for Animal Research Facilities and to Support Care of Animal Models (R41/R42 Clinical Trial Not Allowed) PAR-21-226 ORIP 04/30/2021 Standard dates apply The first standard due date f...(see announcement for full details) 09/06/2024 Not Allowed
Novel Tools and Devices for Animal Research Facilities and to Support Care of Animal Models (R43/R44 Clinical Trial Not Allowed) PAR-21-225 ORIP 04/30/2021 Standard dates apply The first standard due date f...(see announcement for full details) 09/06/2024 Not Allowed
SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1 Clinical Trial Required) PAR-23-220 ODNEINHLBINIANIAAANIDCDNIMH 07/12/2023 Multiple dates, see announcement....(see announcement for full details) 04/06/2025 Required
SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1, Clinical Trial Not Allowed) PAR-23-219 ODNCATSNCINEINHGRINHLBINIAAANIAIDNIAMSNIBIBNIDCDNIDCRNIDDKNIEHSNIMHNINDS 07/12/2023 Multiple dates, see announcement....(see announcement for full details) 04/06/2025 Not Allowed
Seeking Products to Address Social Needs impacting Substance Use Disorders (SUD) (R41/R42 Clinical Trial Optional) RFA-DA-25-047 NIDA 09/28/2023 03/14/2026 Optional
Seeking Products to Address Social Needs impacting Substance Use Disorders (SUD) (R43/R44 Clinical Trial Optional) RFA-DA-25-048 NIDA 09/28/2023 03/14/2026 Optional
Solutions to Enable Regional Genomic Medicine eConsult Services (R41/R42 Clinical Trial Optional) PAR-24-107 NHGRI 01/09/2024 May 30, 2024...(see announcement for full details) 05/31/2024 Optional
Solutions to Enable Regional Genomic Medicine eConsult Services (R43/R44 Clinical Trial Optional) PAR-24-106 NHGRI 01/09/2024 May 30, 2024...(see announcement for full details) 05/31/2024 Optional
Technologies for Improving Minority Health and Eliminating Health Disparities (R41/R42- Clinical Trial Optional) RFA-MD-24-007 NIMHDNCATSNIBIBNIDCRNINR 03/08/2024 Multiple dates, see announcement....(see announcement for full details) 12/10/2026 Optional
Tools for Decentralized Clinical Trials for Substance Use Disorder (R41/R42 Clinical Trials Optional) RFA-DA-25-051 NIDA 10/25/2023 03/15/2024 Optional
Tools for decentralized clinical trials for substance use disorder (R43/R44 Clinical Trials Optional) RFA-DA-25-052 NIDA 10/25/2023 03/15/2024 Optional